Short Communication
Simultaneous determination of sildenafil citrate and some nitric oxide releasing drugs in human plasma using UPLC MS/MS

https://doi.org/10.1016/j.clinbiochem.2014.03.009Get rights and content

Highlights

  • Erectile dysfunction and angina patients may receive drugs/foods affecting NO levels.

  • UPLC-MS/MS method for determination of SLD, L-Arg, and nicorandil was developed.

  • The method is useful to assess synergistic drug-drug and drug-food interactions.

Abstract

Objective

The inadvertent combination of sildenafil (SLD) and nitric oxide releasing compounds (NRC) may cause a life threatening hypotension and conversion of coital angina into an irreversible one. The aim of this study was to develop and validate a UPLC MS/MS method for the simultaneous quantitative analysis of SLD, nicorandil (NRD), and ARG in human plasma to determine the safety margins for drug combinations.

Design and method

Chromatographic elution was achieved in 4 min using gradient elution and an injection volume of 10 μL. Electro-spray positive ionization (ESI+ve) detection and multiple-reaction monitoring mode (MRM) were used for detection.

Results

The method was found to be linear (10–900 ng/mL for SLD and NRD while 1–30 μg/mL for ARG), accurate and precise (99.35 ± 1.58, 99.62 ± 1.13, and 100.04 ± 1.22% for SLD, NRD and ARG; respectively) and met all other validation requirements.

Conclusion

The developed UPLC MS/MS method is suitable for fast, sensitive, accurate and simultaneous determinations of SLD, NRD, and ARG in plasma.

Graphical abstract

Simultaneous administration of sildenafil and nitric oxide releasing compounds (NRCs) is contraindicated as it may result in severe hypotension. NRCs include nicorandil, used to treat angina, and l-arginine rich foods. This paper describes an LC–MS/MS method for the simultaneous determination of sildenafil and some NO releasing compounds in human plasma. This method may be useful for assessing synergistic effects of drugs and foods that affect nitric oxide levels in patients with erectile dysfunction and angina.

  1. Download : Download full-size image

Introduction

Sildenafil citrate (SLD), a selective inhibitor of the phosphodiesterase type 5 (PDE5), is an FDA-approved drug for erectile dysfunction (ED) [1]. Nicorandil (NRD) is a nicotinamide ester which acts as a NO donor, a β-blocker, and a calcium antagonist. It is used widely for treatment of stable angina [2]. ARG, a non/semi-essential amino acid, is abundant in many food supplements and a natural source of NO. It is used to aid treatments of heart and blood vessel conditions and as a male enhancing agents for ED [3].

Angina patients usually suffer ED; thus may receive male enhancing agents containing ARG, herbal medications adulterated with SLD, food products containing ARG, or over the counter SLD [4]. Co-administration of sildenafil and NO-rich compounds is contraindicated. When these two types of pharmacologic agents are co-administered inadvertently, cyclic guanosine monophosphate (cGMP) accumulates leading to marked vasodilatations and hypotension. The resulting hypotension may transform physiological angina from a reversible situation into an irreversible angina (Fig. 1) [4].

Several methods for individual analysis of SLD, NRD and ARG in plasma have been reported which have high sensitivity but are lengthy and incapable of simultaneous determination of the three analytes [5], [6], [7], [8], [9], [10]. This study describes a new UPLC–MS/MS method with small sample size (10 μL), short runtime (4 min) and easy sample preparation steps for the simultaneous determination of SLD, NRD, and ARG.

Section snippets

Materials and methods

SLD, NRD, and pregapalin (PRG) were obtained from NODQCAR (Egypt). Methanol, acetonitrile (HPLC grade), formic acid, acetic acid, ammonium acetate, tri-fluoroacetic acid (TFA) and ARG were purchased from Sigma-Aldrich (Germany). Millipore deionized (DI) water was used throughout the experiment. All other reagents were analytical grade. Human plasma was purchased from VACSERA (Egypt) and contained ARG of 3.84 μg/mL.

Acquity UPLC–MS/MS equipped with UPLC BEH C18 column (5 mm × 2.1 mm; 1.7 μm) and

Results and discussion

Selected transitions for MRM were 475.33 > 57.97 m/z, 212.02 > 136.05 m/z, 175.02 > 70.05 m/z and 159.89 > 55 m/z for SLD, NRD, ARG and PRG; respectively. The optimal scanning conditions are displayed in Table 1. The 3 drugs and the IS were separated at 2.85, 0.85, 0.45 and 0.62 min for SLD, NRD, ARG and PRG, respectively using gradient elution (Fig. 2).

The developed method was valid in terms of linearity (10–900 ng/mL for SLD and NRD while in range 1–30 μg/mL for ARG) in plasma based calibration curve. The

Conclusions

The developed LC–MS/MS method can be used for accurate and simultaneous determination of SLD, NRD, and ARG. The method can also be applied for the bioequivalence studies of SLD and NRD and other pharmacological studies to determine the safety margins for drug combinations. It may be also applied in health care/emergency settings to manage patients suspected of receiving combinations of SLD, NRCs, and/or arginine-rich foods.

Acknowledgment

This work has been funded by a grant from Yousef Jameel Science & Technology Research Center, School of Sciences & Engineering, AUC to Prof. Hassan Azzazy.

Cited by (0)

View full text